Navegando por Assunto "Ocitocina"

Agora exibindo 1 - 2 de 2

Acesso aberto (Open Access)
Modulação dos sistemas GABAérgico e glutamatérgico na secreção hipotalâmica de ocitocina sob condições hiperosmóticas
(Universidade Federal do Pará, 2014-04-07) GRISÓLIA, Alan Barroso Araújo; SILVA, Anderson Manoel Herculano Oliveira da; http://lattes.cnpq.br/8407177208423247; DINIZ, Domingos Luiz Wanderley Picanço; http://lattes.cnpq.br/9601463988942971
In mammals, the osmolality of extracellular fluid is a main factor for maintenance hydro electrolyte balance. Thus, changes in osmolality are detected by specialized hypothalamic cell, thereby starting a neurochemical signaling with glutamatergic and GABAergic system involvement, which may trigger the oxytocin release. However, the way of GABA glutamate aminoacids relationship could modulate the oxytocin release under hyperosmolality is till poorly understood. In this context, the aim in present study was characterize the hypertonic medium effect in GABA glutamate extracellular levels and its relationship with oxytocin release in the hypothalamus in vitro. For this, male wistar rats (270-300g) were kept under standard laboratory conditions. After decapitation, the brain was quickly removed and the hypothalamic fragments were immediately dissected in cold Krebs Ringer Bicarbonate Glucose Buffer (KRBG), and were transferred to perifusion chambers containing KRBG isotonic (280 mOsm/Kg H₂O), at flow rate of 0.5-1.0 ml/min, medium effluent was collected every during 15 min. The hypertonic stimulation (340 mOsm/kg H2O) was performed during 3 minutes. Glutamate, GABA and oxytocin levels were determined by reverse phase high-performance liquid chromatograph (HPLC) system. The measurements of glutamate showed an increased release only after decrease in GABA concentration. This release temporal profile motivated us to add GABA (3 mM) during osmotic stimulation, resulting in blockage of glutamate release previously observed. Moreover the results showed oxtocin release by hypertonic solution may also depend on a GABA decrease. The present study suggests that oxytocin release stimulated by hypertonicity depends on altering the relationship GABA / glutamate.
Acesso aberto (Open Access)
Modulação nitrérgica na regulação ocitocinérgica da secreção do peptídeo natriurético atrial em cardiomiócitos
(Universidade Federal do Pará, 2013-12-18) CONDE, Valney Mara Gomes; DINIZ, Domingos Luiz Wanderley Picanço; http://lattes.cnpq.br/9601463988942971
Oxytocin (OT) was recently shown to be involved in endocrine and neuroendocrine regulation through receptor-mediated actions exerted on the heart, vasculature, and kidney. Oxytocin is a neuropeptide synthesized primarily in magnocellular neurons in the paraventricular and supraoptic nuclei of the hypothalamus, which project to posterior pituitary, median eminence, and several brain regions. Oxytocin is also produced in peripheral tissues, including the heart. In addition, nitric oxide (NO) may be generated constitutively within the heart. This work was performed to verify the role of oxytocin and nitrergic modulation on atrial natriuretic peptide (ANP) secretion in primary culture of mice embryo cardiac myocytes. Cardiomyocytes were isolated from Balb C mice embryo and cultivated by 3 days for obtain an optimal basal ANP secretion. After the exchange by a fresh medium containing OT (0.1, 1, 10 and 100 μM), a dose-dependent increase in ANP and nitrate release was observed, suggesting that OT may have a direct stimulatory action on cardiomyocytes and that action may be related to nitric oxide production. Blockage of 10 μM OT-induced ANP release were observed after addiction of 100 μM Compound VI [d(CH2)5, Tyr(Me)2, Thr4, Tyr-NH2(9)]-Ornitin Vasotocin (CVI-OVT), a specific OT antagonist. This antagonist induced a decrease in ANP release when added alone (100 μM), suggesting that OT may act by a tonic inhibitory autocrine mechanism on ANP secretion. A amplification of OT-induced ANP release was observed after addiction of 600 μM N(G) nitro-L-arginine methylester (L-NAME), a NO synthase inhibitor, and 100 μM 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ), a soluble guanylate cyclase inhibitor, suggesting that a nitrergic negative feedback may act restraining the ANP release stimulated by OT.